218 related articles for article (PubMed ID: 35687785)
1. Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends.
Devereaux KA; Souers RJ; Merker JD; Lindeman NI; Graham RP; Hameed MR; Vasalos P; Moncur JT; Lockwood CM; Xian RR
Arch Pathol Lab Med; 2023 Apr; 147(4):425-433. PubMed ID: 35687785
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on
Surrey LF; Oakley FD; Merker JD; Long TA; Vasalos P; Moncur JT; Kim AS
Arch Pathol Lab Med; 2019 Aug; 143(8):980-984. PubMed ID: 30865489
[TBL] [Abstract][Full Text] [Related]
3. Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the
Moncur JT; Bartley AN; Bridge JA; Kamel-Reid S; Lazar AJ; Lindeman NI; Long TA; Merker JD; Rai AJ; Rimm DL; Rothberg PG; Vasalos P; Kim AS
Arch Pathol Lab Med; 2019 Oct; 143(10):1203-1211. PubMed ID: 30969158
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing.
Kim AS; Bartley AN; Bridge JA; Kamel-Reid S; Lazar AJ; Lindeman NI; Long TA; Merker JD; Rai AJ; Rimm DL; Rothberg PG; Vasalos P; Moncur JT
JAMA Oncol; 2018 Jun; 4(6):838-841. PubMed ID: 29242895
[TBL] [Abstract][Full Text] [Related]
5. Four-Year Laboratory Performance of the First College of American Pathologists In Silico Next-Generation Sequencing Bioinformatics Proficiency Testing Surveys.
Furtado LV; Souers RJ; Vasalos P; Halley JG; Aisner DL; Nagarajan R; Voelkerding KV; Merker JD; Konnick EQ
Arch Pathol Lab Med; 2023 Feb; 147(2):137-142. PubMed ID: 35671151
[TBL] [Abstract][Full Text] [Related]
6. SPOT/Dx Pilot Reanalysis and College of American Pathologists Proficiency Testing for KRAS and NRAS Demonstrate Excellent Laboratory Performance.
Zehir A; Nardi V; Konnick EQ; Lockwood CM; Long TA; Sidiropoulos N; Souers RJ; Vasalos P; Lindeman NI; Moncur JT
Arch Pathol Lab Med; 2024 Feb; 148(2):139-148. PubMed ID: 37776255
[TBL] [Abstract][Full Text] [Related]
7. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
[TBL] [Abstract][Full Text] [Related]
8. Implementation, Evolution, and Laboratory Performance of Methods-Based Proficiency Testing for Next-Generation Sequencing Detection of Germline Sequence Variants.
Tsuchiya KD; Funke B; Hegde M; Santani A; Souers RJ; Szelinger S; Halley J; Zhao Q; Mot N; Roy A; Smith VL; Zhang BM; Voelkerding K; Moyer AM
Arch Pathol Lab Med; 2024 Jul; 148(7):775-783. PubMed ID: 37852169
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy for detection of EGFR T790M mutation in nonsmall cell lung cancer: An experience of proficiency testing in Taiwan.
Ho HL; Huang CC; Ku WH; Ho CL; Lin CH; Yu SL; Chou TY
J Chin Med Assoc; 2019 Jun; 82(6):473-476. PubMed ID: 30932938
[TBL] [Abstract][Full Text] [Related]
10. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies.
Zhang BM; Keegan A; Li P; Lindeman NI; Nagarajan R; Routbort MJ; Vasalos P; Kim AS; Merker JD
Arch Pathol Lab Med; 2021 Sep; 145(9):1110-1116. PubMed ID: 33450747
[TBL] [Abstract][Full Text] [Related]
11. A Model Study of In Silico Proficiency Testing for Clinical Next-Generation Sequencing.
Duncavage EJ; Abel HJ; Merker JD; Bodner JB; Zhao Q; Voelkerding KV; Pfeifer JD
Arch Pathol Lab Med; 2016 Oct; 140(10):1085-91. PubMed ID: 27388684
[TBL] [Abstract][Full Text] [Related]
12. Next-Generation Sequencing Somatic and Germline Assay Troubleshooting Guide Derived From Proficiency Testing Data.
Nardi V; Tsuchiya KD; Kim AS; Bean LJH; Halley JG; Long TA; Szelinger S; Vasalos P; Thorson JA; Moyer AM; Moncur JT
Arch Pathol Lab Med; 2022 Apr; 146(4):451-461. PubMed ID: 34424952
[TBL] [Abstract][Full Text] [Related]
13. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
[TBL] [Abstract][Full Text] [Related]
14. Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid.
Mehrotra M; Singh RR; Chen W; Huang RSP; Almohammedsalim AA; Barkoh BA; Simien CM; Hernandez M; Behrens C; Patel KP; Routbort MJ; Broaddus RR; Medeiros LJ; Wistuba II; Kopetz S; Luthra R
J Mol Diagn; 2017 Jul; 19(4):514-524. PubMed ID: 28506684
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
Iwama E; Sakai K; Azuma K; Harada T; Harada D; Nosaki K; Hotta K; Ohyanagi F; Kurata T; Fukuhara T; Akamatsu H; Goto K; Shimose T; Kishimoto J; Nakanishi Y; Nishio K; Okamoto I
Ann Oncol; 2017 Jan; 28(1):136-141. PubMed ID: 28177428
[TBL] [Abstract][Full Text] [Related]
16. Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey.
Hupp MM; Bashleben C; Cardinali JL; Dorfman DM; Karlon W; Keeney M; Leith C; Long T; Murphy CE; Pillai V; Rosado FN; Seegmiller AC; Linden MA
Arch Pathol Lab Med; 2021 Mar; 145(3):336-342. PubMed ID: 32886757
[TBL] [Abstract][Full Text] [Related]
17. External Quality Assurance of Current Technology for the Testing of Cancer-Associated Circulating Free DNA Variants.
Chai SY; Peng R; Zhang R; Zhou L; Pillay N; Tay KH; Badrick T; Li J; Horan MP
Pathol Oncol Res; 2020 Jul; 26(3):1595-1603. PubMed ID: 31487000
[TBL] [Abstract][Full Text] [Related]
18. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.
Xu X; Huang F; Cao M; Chen X; Wang H; Jiang H; Yu Y; Shen M; Yang Y; Wang B; Liu T; Guo W
J Clin Lab Anal; 2021 Sep; 35(9):e23818. PubMed ID: 34403504
[TBL] [Abstract][Full Text] [Related]
19. Construction of a reference material panel for detecting
Xu J; Qu S; Sun N; Zhang W; Zhang J; Song Q; Lin M; Gao W; Zheng Q; Han M; Na C; Xu R; Chang X; Yang X; Huang J
J Clin Pathol; 2021 May; 74(5):314-320. PubMed ID: 32817175
[TBL] [Abstract][Full Text] [Related]
20. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients.
Macías M; Cañada-Higueras E; Alegre E; Bielsa A; Gracia J; Patiño-García A; Ferrer-Costa R; Sendino T; Andueza MP; Mateos B; Rodríguez J; Corral J; Gúrpide A; Lopez-Picazo JM; Perez-Gracia JL; Gil-Bazo I; Alkorta-Aranburu G; González Á
Clin Chem Lab Med; 2020 Jul; 58(8):1341-1348. PubMed ID: 32623849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
